======= LIFR ======= == Gene Information == * **Official Symbol**: LIFR * **Official Name**: LIF receptor subunit alpha * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3977|3977]] * **UniProt**: [[https://www.uniprot.org/uniprot/P42702|P42702]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LIFR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LIFR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/151443|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that belongs to the type I cytokine receptor family. This protein combines with a high-affinity converter subunit, gp130, to form a receptor complex that mediates the action of the leukemia inhibitory factor, a polyfunctional cytokine that is involved in cellular differentiation, proliferation and survival in the adult and the embryo. Mutations in this gene cause Schwartz-Jampel syndrome type 2, a disease belonging to the group of the bent-bone dysplasias. A translocation that involves the promoter of this gene, t(5;8)(p13;q12) with the pleiomorphic adenoma gene 1, is associated with salivary gland pleiomorphic adenoma, a common type of benign epithelial tumor of the salivary gland. Multiple splice variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Signal-transducing molecule. May have a common pathway with IL6ST. The soluble form inhibits the biological activity of LIF by blocking its binding to receptors on target cells. |fn3| |leukemia inhibitory factor receptor activity| |oncostatin-M receptor activity| |oncostatin-M-mediated signaling pathway| |leukemia inhibitory factor signaling pathway| |ciliary neurotrophic factor receptor binding| |ciliary neurotrophic factor receptor activity| |ciliary neurotrophic factor-mediated signaling pathway| |growth factor binding| |cytokine binding| |cytokine receptor activity| |regulation of cytokine-mediated signaling pathway| |regulation of response to cytokine stimulus| |receptor complex| |external side of plasma membrane| |cytokine-mediated signaling pathway| |enzyme linked receptor protein signaling pathway| |positive regulation of cell population proliferation| |cellular response to cytokine stimulus| |response to cytokine| |integral component of plasma membrane| |regulation of cell population proliferation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-2.15| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|-2.09| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-1.78| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|-1.77| |[[:results:exp292|Menadione 5μM R06 exp292]]|1.82| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|1.9| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 17908 * **Expression level (log2 read counts)**: -0.54 {{:chemogenomics:nalm6 dist.png?nolink |}}